Guangzhou Xiling Biotechnology Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Guangzhou Xiling Biotechnology Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Safety and Tolerability Evaluation of CEL001 Injection in Advanced Solid Tumors (NCT07259889) | Guangzhou Xiling Biotechnology Co., Ltd. | 2025-06-16 |
Track Guangzhou Xiling Biotechnology Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.